Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy

To compare the continuous subcutaneous insulin infusion (CSII) or insulin glargine based multiple injections (MDI) therapy on glycemic variations in diabetic patients receiving PN outside of intensive care settings. This was a single-center, randomized, open-label trial. Patients with type 2 diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feng-fei, Zhang, Wen-li, Liu, Bing-li, Zhang, Dan-feng, Chen, Wei, Yuan, Li, Chen, Mao-yuan, Zhai, Xiao-fang, Wu, Jin-dan, Su, Xiao-fei, Ye, Lei, Cao, Hong-yong, Ma, Jian-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897521/
https://www.ncbi.nlm.nih.gov/pubmed/29651052
http://dx.doi.org/10.1038/s41598-018-24275-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897521/
https://www.ncbi.nlm.nih.gov/pubmed/29651052
http://dx.doi.org/10.1038/s41598-018-24275-5

Ejemplares similares